HCPCS codes

22723 HCPCS codes with hospital pricing data in the network.

• HCPCS S2095 — Transcatheter embolization with microspheresAI (660 hospitals, 3–30 samples)
• HCPCS S2325 — Hip core decompression surgeryAI (518 hospitals, 3–30 samples)
• HCPCS T2023 — Targeted case management, monthlyAI (275 hospitals, 3–30 samples)
• HCPCS U0004 — COVID-19 test, high-throughput non-CDC methodAI (563 hospitals, 3–30 samples)
• HCPCS V5040 — Bone-conduction body-worn hearing aidAI (406 hospitals, 3–30 samples)
• HCPCS C2614 — Percutaneous lumbar disc probeAI (394 hospitals, 3–30 samples)
• HCPCS C8926 — Heart ultrasound through the esophagus with contrast, for congenital heart defectsAI (1121 hospitals, 3–30 samples)
• HCPCS C2626 — Pain pump catheter system for surgical siteAI (584 hospitals, 3–30 samples)
• HCPCS A9272 — Wound suction dressing and access suppliesAI (485 hospitals, 3–30 samples)
• HCPCS C2698 — Brachytherapy stranded radioactive seeds, unspecifiedAI (722 hospitals, 3–30 samples)
• HCPCS A4566 — Shoulder sling or vest restraintAI (358 hospitals, 3–30 samples)
• HCPCS J2601 — Injection of vasopressin, 1 unitAI (1182 hospitals, 3–30 samples)
• HCPCS A2027 — Matriderm skin substitute, per square centimeterAI (601 hospitals, 3–30 samples)
• HCPCS A4220 — Refill kit for drug infusion pumpAI (519 hospitals, 3–30 samples)
• HCPCS A6505 — DME POS (287 hospitals, 3–30 samples)
• HCPCS A7035 — CPAP headgearAI (669 hospitals, 3–30 samples)
• HCPCS A9279 — Other monitoring device or add-on, not specifiedAI (337 hospitals, 3–30 samples)
• HCPCS C1600 — Bladed vascular prep catheterAI (277 hospitals, 3–30 samples)
• HCPCS C1738 — Ultrasound-guided fine needle biopsy deviceAI (354 hospitals, 3–30 samples)
• HCPCS E0141 — Rigid wheeled walker with adjustable heightAI (654 hospitals, 3–30 samples)
• HCPCS E0155 — Wheel attachments for rigid pick-up walker (pair)AI (647 hospitals, 3–30 samples)
• HCPCS J7171 — Injection of recombinant ADAMTS13 enzyme, 10 IUAI (1131 hospitals, 3–30 samples)
• HCPCS J9248 — Melphalan injection (Hepzato), per milligramAI (1068 hospitals, 3–30 samples)
• HCPCS Q4309 — Skin substitute matrix, per square centimeterAI (867 hospitals, 3–30 samples)
• HCPCS S0613 — Annual breast examAI (322 hospitals, 3–30 samples)
• HCPCS S5551 — Rapid-acting insulin, 5 unitsAI (634 hospitals, 3–30 samples)
• HCPCS S8185 — Flutter breathing deviceAI (333 hospitals, 3–30 samples)
• HCPCS D9223 — General anesthesia, each additional 15 minutesAI (288 hospitals, 3–30 samples)
• HCPCS E0700 — SAFETY EQUIPMENTAI (334 hospitals, 3–30 samples)
• HCPCS H2015 — Community psychiatric support service, 15 minutesAI (253 hospitals, 3–30 samples)
• HCPCS L0452 — DME POS (336 hospitals, 3–30 samples)
• HCPCS S9128 — Speech therapy at homeAI (289 hospitals, 3–30 samples)
• HCPCS C9306 — APC (325 hospitals, 3–30 samples)
• HCPCS A4210 — NONNEEDLE INJECTION DEVICEAI (433 hospitals, 18–27 samples)
• HCPCS G0317 — Prolonged nursing facility evaluation, 15 minutesAI (759 hospitals, 26 samples)
• HCPCS L2405 — Knee joint drop lock additionAI (992 hospitals, 17–26 samples)
• HCPCS L2780 — Non-corrosive finish add-on for leg brace barAI (1010 hospitals, 17–26 samples)
• HCPCS B4160 — Pediatric high-calorie enteral feeding formulaAI (427 hospitals, 16–25 samples)
• HCPCS M0243 — Casirivimab and imdevimab injectionAI (1236 hospitals, 25 samples)
• HCPCS M0244 — Casirivimab and imdevimab injectionAI (561 hospitals, 25 samples)
• HCPCS M0247 — SOTROVIMAB INFUSIONAI (1135 hospitals, 25 samples)
• HCPCS T2034 — Daily mental health crisis intervention under waiver programAI (158 hospitals, 15–24 samples)
• HCPCS G1028 — Take-home naloxone nasal spray supplyAI (354 hospitals, 13–22 samples)
• HCPCS G0159 — Home health physical therapy maintenance, per 15 minutesAI (273 hospitals, 13–22 samples)
• HCPCS J0607 — Lanthanum carbonate oral medicine, 5 mgAI (984 hospitals, 13–22 samples)
• HCPCS H0039 — In-person assertive community treatment, billed per 15 minutesAI (193 hospitals, 21 samples)
• HCPCS Q5005 — Inpatient hospice careAI (275 hospitals, 12–21 samples)
• HCPCS C5277 — Skin substitute application, low-cost productAI (1288 hospitals, 2–20 samples)
• HCPCS C8919 — MR angiography of pelvis without contrastAI (1529 hospitals, 2–20 samples)
• HCPCS M0249 — Tocilizumab infusion, first doseAI (1504 hospitals, 2–20 samples)